CONNECT WITH US
HealthTech

HealthTech

Artiva to wind down after two patient deaths in autoimmune cell therapy trials

Endpoints News logo

Published on

Add as a preferred source on Google
Artiva to wind down after two patient deaths in autoimmune cell therapy trials

Arti­va to wind down af­ter two pa­tient deaths in au­toim­mune cell ther­a­py tri­als

Cell ther­a­py biotech Arti­va Bio­ther­a­peu­tics abrupt­ly an­nounced Tues­day morn­ing that it is ef­fec­tive­ly shut­ting down and lay­ing off al­most all of its staff af­ter two …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Q&A: Bris­tol My­ers’ Lynelle Hoch on au­toim­mune CAR-T safe­ty chal­lenges, MS pa­tient death October 23, 2026

Bris­tol My­ers re­veals death in MS CAR-T tri­al, has an­swer for safe­ty sig­nal in lu­pus tri­al October 23, 2026

Chi­na biotech Ri­boX re­veals first da­ta of cir­cu­lar RNA ther­a­pies in peo­ple October 21, 2026

Post-Makary FDA wins over in­vestors, but not sci­en­tists or Big Phar­ma: Sig­nal Sur­vey



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.